好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Status Epilepticus Network Linking Peri-Ictal MRI Abnormalities to Metabolic Demand and Glutamate Signaling
Epilepsy/Clinical Neurophysiology (EEG)
S36 - Epilepsy Basic Mechanisms, Status Epilepticus, and Mortality (1:48 PM-2:00 PM)
005

Status epilepticus (SE) is a severe, protracted seizure often resistant to antiseizure medications. Its pathophysiology is unclear, with seizures potentially arising from various brain regions. SE is frequently accompanied with peri-ictal MRI abnormalities (PMA), which could reveal new insights into its implicated brain network and lead to new therapeutic targets.

To identify and validate a status epilepticus network

We identified 73 published cases of SE-related diffusion restriction and used lesion network mapping to identify a common brain network. Locations of diffusion restriction from ischemic stroke (n=490) served as controls. We identified an SE network using a voxel-wise t-test with 10,000 permutations and tested whether lesion overlap with this SE network could predict SE in an independent prospective cohort. The validation cohort consisted of 47 patients with SE-related diffusion restriction versus 120 of another etiology (stroke, tumor, infection etc.). To contextualize our findings, we compared the locations of diffusion restriction and  SE network to maps of metabolic demand (FDG-PET) and distributions of gene expression derived from the Allen Human Brain Atlas. 

SE-related PMAs were connected to the medial pulvinar thalamus and precuneus cortex (>85% sensitive, PFWE < 0.05 specific). We derived an SE network using these regions, which showed functional connectivity to the limbic system, default mode network, septum, claustrum, tectum, and cerebellum. Lesion overlap with the identified SE network predicted SE in an independent cohort (AUC = 0.883, p < 0.001), improving significantly (D = 2.931, df = 306.86, p = 0.004) over an FDG-PET map of metabolic demand (AUC=0.703, p < 0.001). The SE network spatially correlated with gene distributions for HOMER2 and metabotropic glutamate receptors 5 and 7.

We identified an SE network that discriminates SE-related diffusion restriction from other etiologies and enhances our understanding of seizure circuits, which could lead to novel treatment targets for ongoing seizures.  

Authors/Disclosures
Neal Nolan, MD
PRESENTER
Dr. Nolan has received personal compensation for serving as an employee of Vertex Pharmaceuticals and Rapport Therapeutics. Dr. Nolan has stock in Rapport Therapeutics.
Frederic Schaper, MD, PhD (Brigham and Women's) Dr. Schaper has nothing to disclose.
Payam Tabaee Damavandi, MD, FEBN Dr. Tabaee Damavandi has nothing to disclose.
Joseph I. Turner Mr. Turner has nothing to disclose.
Ross MacFadyen, Researcher Mr. MacFadyen has nothing to disclose.
William Drew (Brigham and Women's Hospital) Mr. Drew has nothing to disclose.
Bassam Al-Fatly, MBChB MSc FEBN Dr. Al-Fatly has nothing to disclose.
Clemens Neudorfer Dr. Neudorfer has nothing to disclose.
Natalia S. Rost, MD, MPH, FAHA, FAAN (Massachusetts General Hospital) Dr. Rost has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for 好色先生. Dr. Rost has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke - AHA/ASA Journal. The institution of Dr. Rost has received research support from NIH. Dr. Rost has received publishing royalties from a publication relating to health care.
Ona Wu (MGH Stroke Research Center) The institution of Ona Wu has received research support from NIH. Ona Wu has received intellectual property interests from a discovery or technology relating to health care. Ona Wu has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH.
Pilar Bosque Varela, MD Pilar Bosque Varela, MD has nothing to disclose.
Lukas Machegger, MD, PhD, MBA Dr. Machegger has nothing to disclose.
Eugen Trinka Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Böhringer Ingelheim. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Everpharma. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Liva-Nova. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Newbridge. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Marinus. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arvelle. Eugen Trinka has received research support from Austrian Science Fund (FWF). Eugen Trinka has received research support from Österreichische Nationalbank. Eugen Trinka has received research support from European Union. Eugen Trinka has received research support from GSK. Eugen Trinka has received research support from Biogen. Eugen Trinka has received research support from Eisai. Eugen Trinka has received research support from Novartis. Eugen Trinka has received research support from Red Bull. Eugen Trinka has received research support from Bayer. Eugen Trinka has received research support from UCB. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a other with Neuroconsult Ges.m.b.H..
Jong W. Lee, MD, PhD (Brigham and Women's Hospital) The institution of Dr. Lee has received research support from NIH. The institution of Dr. Lee has received research support from NIH. The institution of Dr. Lee has received research support from UCB. Dr. Lee has received personal compensation in the range of $10,000-$49,999 for serving as a Contract work with Teladoc.
Giorgi Kuchukhidze (Salzburg University) No disclosure on file
Michael D. Fox, MD, PhD (Brigham and Women's Hospital / Harvard Medical School) Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley.